New Delhi: Alembic Pharmaceuticals Limited has incorporated a wholly owned subsidiary, Alembic Pharmaceuticals GmbH, in Germany with an initial share capital of EUR 25,000, as part of its strategy to ...

Alembic Pharmaceuticals Limited has received final approval from the US Food and Drug Administration (USFDA) for its generic methotrexate injection, marking a significant addition to its oncology and ...

Vadodara: Alembic Pharmaceuticals is adding another regulated-market approval to its portfolio, reinforcing its presence in the US generics space with a key oncology and autoimmune therapy product.

Alembic Pharmaceuticals just got the green light from the US Food and Drug Administration for its generic methotrexate injection, available in two vial sizes. This medicine is used to treat certain ...

Alembic Pharmaceuticals Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Methotrexate Injection USP, the company ...

New Delhi: Alembic Pharmaceuticals Limited has received final approval from the United States Food and Drug Administration (USFDA) for its Dapagliflozin Tablets in strengths of 5 mg and 10 mg, the ...

Vadodara: Alembic Pharmaceuticals has strengthened its US generics portfolio with a key regulatory approval, positioning itself to tap into a high-value diabetes treatment market. Alembic ...

Alembic Pharmaceuticals receives USFDA approval for generic dapagliflozin tablets (5mg & 10mg) to control blood sugar in type-2 diabetes. New Delhi, Apr 7 (PTI) Alembic Pharmaceuticals Ltd on Tuesday ...

Feb 5 (Reuters) - Indian drugmaker Alembic Pharmaceuticals (ALEM.NS), opens new tab on Thursday reported lower third‑quarter profit on Thursday after taking a one-time charge linked to India's new ...

Send a note to Doug Wintemute, Kara Coleman Fields and our other editors. We read every email. By submitting this form, you agree to allow us to collect, store, and potentially publish your provided ...

International consultancy Accenture announced last week that it had invested in AI startup Alembic, kickstarting a partnership that will leverage the technology to better measure the effectiveness of ...

Causal artificial intelligence startup Alembic Technologies Inc. said today it has raised $145 million in a Series B growth round that increases its valuation almost 16-fold. It’s using a big chunk of ...